Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Unblinded Trial Evaluating a 12-week Autism-adapted Group Cognitive Behavioural Therapy Versus Treatment as Usual Adults (18+) With Autism Spectrum Diagnosis and Co-occurring Anxiety and/or Depressive Disorders.

NCT07880028 is registered in ClinicalTrials.gov with Lovisenberg Diakonale Hospital as lead sponsor.

NCT NCT07880028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07880028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Unblinded Trial Evaluating a 12-week Autism-adapted Group Cognitive Behavioural Therapy Versus Treatment as Usual Adults (18+) With Autism Spectrum Diagnosis and Co-occurring Anxiety and/or Depressive Disorders.
Lead sponsor
Lovisenberg Diakonale Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 19, 2026
Completion date
September 1, 2031
Enrollment
154 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, autism spectrum disorder (asd), depression